Zweck, Elric <br/><br/>
GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects?  [electronic resource] 

 -  The lancet. Diabetes & endocrinology  02 2019 
 - 89-90 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>2213-8595 
<br/><br/><label>Standard No.: </label>10.1016/S2213-8587(18)30351-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Diseases<br/>Cardiovascular System<br/>Diabetes Mellitus, Type 2<br/>Glucagon-Like Peptide-1 Receptor<br/>Humans<br/>Hypoglycemic Agents